We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Sansure Biotech Inc

Sansure Biotech is an integrated solutions manufacturer and provider of diagnostic reagents, nucleic acid diagnostic ... read more Featured Products: More products

Download Mobile App





Sansure Biotech Demonstrates iPonatic III Portable Molecular Workstation

By LabMedica International staff writers
Posted on 24 May 2023
Print article
Image: The iPonatic Ⅲ portable molecular workstation at EuroMedlab 2023 (Photo courtesy of Sansure)
Image: The iPonatic Ⅲ portable molecular workstation at EuroMedlab 2023 (Photo courtesy of Sansure)

Sansure Biotech (Hunan, China) is demonstrating its comprehensive range of IVD solutions at EuroMedLab Rome 2023, including the iPonatic III portable molecular workstation.

As a bronze sponsor of the Congress, Sansure is welcoming visitors to its booth where the company’s technicians are showcasing the operations of the iPonatic III portable molecular workstation and presenting its key features and applications. The portable molecular workstation stands out for its ability to deliver extremely accurate test results within 8 to 45 minutes. Equipped with innovative one-tube fast release and rapid PCR amplification technology, it enhances point of care testing (POCT) by optimizing steps such as sample handling, nucleic acid extraction, purification, PCR amplification, and result processing. In addition, the iPonatic III offers a versatile and expandable testing menu, capable of catering to the testing requirements of various pathogens. Its adaptability and portability make it useful in numerous settings, ranging from medical laboratories to emergency rooms. The ultimate objective of this device is to facilitate lab-standard molecular diagnostic services at point-of-care facilities like doctor's offices, clinics, and pharmacies, thereby providing critical support to global healthcare communities.

Among Sansure’s latest developments in the field of diagnostics being presented at the industry event is the newly-launched Natch 16S nucleic acid extraction system. Natch 16S employs magnetic bead technology and boasts ten different mixing modes. It incorporates a built-in UV lamp and air filtration system, touch control, and a 7-inch touchscreen. With the capacity to extract nucleic acid in 10-60 minutes per batch, the Natch 16S finds applications across numerous fields, including sexually transmitted diseases, women's health, respiratory diseases, gastrointestinal diseases, prenatal and postnatal care, and public health.

Related Links:
Sansure Biotech

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.